{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:10:57Z","timestamp":1791054657705,"version":"4.1.0"},"reference-count":181,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":6490,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1995,6]]},"abstract":"<jats:p>Serotonin, or 5\u2010hydroxytryptamine, is a naturally\u2010occurring vasoactive substance found primarily in the brain, enterochromaffin tissue, and blood platelets. It has diffuse cardiophysiologic effects. The multiple effects of serotonin on blood vessels can be explained by the existence of 2 serotonergic receptor subtypes (the S<jats:sub>1<\/jats:sub>receptor mediates vasodilation, and the S<jats:sub>2<\/jats:sub>receptor vasoconstriction). Serotonin via the S<jats:sub>2<\/jats:sub>receptor also augments the actions of several other vasoconstricting substances. Serotonin may be responsible for causing, or at least perpetuating, some forms of systemic hypertension through peripheral and central nervous system (CNS) actions. Ketanserin is a highly selective S<jats:sub>2<\/jats:sub>\u2010serotonergic antagonist with additional \u03b1\u2010adrenergic blocking activity, which has been proposed as a therapy for various cardiovascular diseases including hypertension. It has been shown to be more effective than placebo in treating hypertension and comparable in effectiveness to other antihypertensive drugs. Its major side effects relate to the CNS, and prolongation of the electrocardiogram QT interval has been described. Caution must be used when using ketanserin in patients receiving potassium\u2010 and magnesium\u2010losing agents, because of the risk of torsades de pointes. Ketanserin has potential utility in the treatment of eclampsia, peripheral vascular disease, carcinoid syndrome, and \u201cshock lung.\u201d The drug is not yet approved for clinical use in the United States.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1995.tb05013.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T19:21:42Z","timestamp":1362770502000},"page":"541-572","source":"Crossref","is-referenced-by-count":81,"title":["Serotonin and Serotonin Antagonism in Cardiovascular and Non\u2010Cardiovascular Disease"],"prefix":"10.1002","volume":"35","author":[{"given":"William H.","family":"Frishman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seymour","family":"Huberfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Okin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh\u2010Huey","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babar","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/1.3.317S"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198631020-00004"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1954.34.3.563"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00014"},{"issue":"5","key":"e_1_2_1_6_2","first-page":"S116","article-title":"Serotonin and the blood\u2010vessel wall","volume":"4","author":"Cohen R","year":"1986","journal-title":"J Hypertens"},{"issue":"1","key":"e_1_2_1_7_2","first-page":"S29","article-title":"Serotonin and the blood vessel wall","volume":"4","author":"Vanhoutte P","year":"1986","journal-title":"J Hypertens"},{"issue":"1","key":"e_1_2_1_8_2","first-page":"S55","article-title":"Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: Inhibition by ketanserin","volume":"4","author":"Nueten J","year":"1986","journal-title":"J Hypertens"},{"issue":"5","key":"e_1_2_1_9_2","first-page":"S112","article-title":"Serotonin and the blood vessel wall","volume":"4","author":"Vanhoutte P","year":"1986","journal-title":"J Hypertens"},{"issue":"1","key":"e_1_2_1_10_2","first-page":"S23","article-title":"Serotonin and the peripheral circulation","volume":"4","author":"Hollenberg N","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00002"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00015"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00019"},{"key":"e_1_2_1_14_2","first-page":"132","article-title":"The antihypertensive effects of a pure and selective serotonin receptor blocking agent (R 41 468) in elderly patients","volume":"32","author":"Cree J","year":"1982","journal-title":"Angiology"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00003"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00048"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ajh\/1.1.79","article-title":"Central serotonergic mechanisms in hypertension","volume":"1","author":"Chalmers JP","year":"1988","journal-title":"Am J Hypertens"},{"key":"e_1_2_1_18_2","volume-title":"Serotonin and the Cardiovascular System.","author":"Vanhoutte P","year":"1985"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.51.2.149"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01245975"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00016"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00040"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6389.381-a"},{"issue":"1","key":"e_1_2_1_24_2","first-page":"S67","article-title":"Double\u2010blind comparison of ketanserin with atenolol: Antihypertensive activity and effect on platelet function","volume":"4","author":"Kirch W","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.6.1.100"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0038-1646443","article-title":"Antithrombotic effect of MCl\u20109042, a new antiplatelet agent on experimental thrombosis models","volume":"66","author":"Hara H","year":"1991","journal-title":"Thromb Haemostas"},{"issue":"3","key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0038-1651592","article-title":"Antithrombotic activity of SR 46349, a novel, potent and selective 5HT2receptor antagonist","volume":"69","author":"Herbert JM","year":"1993","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0038-1646420","article-title":"LY53857, a 5\u2010HT2 receptor antagonist, delays occlusion and inhibits platelet aggregation in a rabbit model of carotid artery occlusion","volume":"66","author":"Wilson HC","year":"1991","journal-title":"Thromb Haemostas"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00038"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00031"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198503000-00002"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00036"},{"issue":"1","key":"e_1_2_1_33_2","first-page":"S7","article-title":"Ketanserin: Haemodynamic effects and mechanism of action","volume":"4","author":"Schalekamp A","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00032"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.214"},{"key":"e_1_2_1_36_2","first-page":"129","article-title":"Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats","volume":"264","author":"BalaSubramanian H","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.44"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00034"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198609000-00013"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700103-00022"},{"key":"e_1_2_1_41_2","first-page":"736","article-title":"Characterization of the central sympatho\u2010inhibitory action of ketanserin","volume":"241","author":"McCall RB","year":"1987","journal-title":"J Pharm Exp Ther"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30780-5"},{"key":"e_1_2_1_43_2","first-page":"1681","article-title":"Central and autonomic nervous system side effects of ketanserin","volume":"36","author":"Reimann I","year":"1986","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00014"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00012"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609954"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6315.537"},{"issue":"1","key":"e_1_2_1_48_2","first-page":"S13","article-title":"Ketanserin\u2014a new antihypertensive agent","volume":"4","author":"Breckenridge A","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1985.tb02823.x"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90201-5"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02540.x"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.61.717.583"},{"issue":"1","key":"e_1_2_1_53_2","first-page":"S95","article-title":"Renal effects of ketanserin in essential hypertension","volume":"4","author":"Navis G","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198401000-00027"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01037939"},{"issue":"2","key":"e_1_2_1_56_2","first-page":"70","article-title":"Hemodynamic and neurohumoral effects of ketanserin, a 5\u2010HT2 receptor antagonist in patients with congestive heart failure","volume":"3","author":"Majid PA","year":"1987","journal-title":"Can J Cardiol"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00024"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00013"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198801000-00030"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00021"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00029"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90012-9"},{"issue":"1","key":"e_1_2_1_63_2","first-page":"397","article-title":"Electrophysiologic effects of ketanserin on canine Purkinje fibers, ventricular myocardium and the intact heart","volume":"250","author":"Zaza A","year":"1989","journal-title":"J Pharm & Exp Ther"},{"issue":"5","key":"e_1_2_1_64_2","first-page":"630P","article-title":"The effect of ketanserin on the QT interval","volume":"23","author":"Cameron HA","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00021"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90051-9"},{"issue":"3","key":"e_1_2_1_67_2","first-page":"90","article-title":"Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin","volume":"8","author":"Zehender M","year":"1990","journal-title":"Clin Physiol Biochem"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1986.tb06633.x"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6671.424"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00010"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00043"},{"key":"e_1_2_1_72_2","first-page":"100","article-title":"Hemorheological effects of ketanserin, a selective 5HT2\u2010receptor antagonist, in aged, spontaneously hypertensive dogs","volume":"258","author":"Clerck F","year":"1982","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00007"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00006"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02346.x"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.8.2.167"},{"issue":"1","key":"e_1_2_1_77_2","first-page":"S51","article-title":"Effect of ketanserin on the in vitro regulation of aldosterone","volume":"4","author":"Rocco S","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00012"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00046"},{"issue":"1","key":"e_1_2_1_80_2","first-page":"S91","article-title":"Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients","volume":"4","author":"Hedner T","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00049"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb04974.x"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198509000-00031"},{"issue":"3","key":"e_1_2_1_84_2","first-page":"S125","article-title":"Multicenter study with ketanserin in essential hypertension: An Argentine experiment","volume":"10","author":"DeMartini A","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00044"},{"key":"e_1_2_1_86_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archinte.1987.00370020109046","article-title":"Comparison of ketanserin and metoprolol in the treatment of essential hypertension","volume":"147","author":"Sheps S","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00042"},{"issue":"5","key":"e_1_2_1_88_2","first-page":"S29","article-title":"Age\u2010related effects of 5HT2 antagonists","volume":"17","author":"Doyle AE","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_89_2","first-page":"565","article-title":"The anti\u2010hypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement","volume":"4","author":"McCormack PME","year":"1990","journal-title":"J Human Hypertens"},{"key":"e_1_2_1_90_2","first-page":"88","article-title":"Could the increased antihypertensive efficacy of ketanserin in the elderly be due to altered pharmacokinetics?","volume":"4","author":"Gould SE","year":"1990","journal-title":"Cardiol Drugs & Ther"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00041"},{"issue":"1","key":"e_1_2_1_92_2","first-page":"S81","article-title":"Clinical experience with ketanserin in the treatment of hypertension","volume":"4","author":"Palermo A","year":"1986","journal-title":"J Hypertens"},{"issue":"6","key":"e_1_2_1_93_2","first-page":"427","article-title":"Ketanserin in the treatment of essential hypertension: A double\u2010blind study against metoprolol and a further long\u2010term open treatment","author":"Milei J","year":"1986","journal-title":"Acta Cardiol"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03122.x"},{"key":"e_1_2_1_95_2","first-page":"S61","article-title":"Comparison of ketanserin and pindolol in hypertension","author":"Gordin A","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.139"},{"issue":"1","key":"e_1_2_1_97_2","first-page":"S85","article-title":"Moderate essential hypertension control: A double\u2010blind crossover study between a serotonin antagonist and a post\u2010synaptic alpha blocker","volume":"4","author":"Rosenthal J","year":"1986","journal-title":"J Hypertens"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00027"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053443"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700103-00028"},{"issue":"3","key":"e_1_2_1_101_2","first-page":"S119","article-title":"Antihypertensive efficacy of ketanserin alone or in combination with a \u03b2\u2010blocker or a diuretic: The Swiss Ketanserin Study","volume":"10","author":"Beretta\u2010Piccoli C","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053442"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00030"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.32.307"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706103-00031"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1983.tb08583.x"},{"key":"e_1_2_1_107_2","first-page":"120","article-title":"Effects of intravenous ketanserin on severely hypertensive patients with double\u2010blind crossover assessment of central side effects","volume":"9","author":"Jennings A","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00047"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1159\/000292996"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(84)90023-1"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(85)90095-X"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90802-1"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700103-00025"},{"key":"e_1_2_1_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331978603701104"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00045"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03029743"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00025"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90704-9"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91553-3"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500077-00026"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198511000-00011"},{"key":"e_1_2_1_122_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/000331978703800708","article-title":"Placebo\u2010controlled double\u2010blind trial of ketanserin in the treatment of intermittent claudication","author":"Cameron HA","year":"1987","journal-title":"Angiology"},{"key":"e_1_2_1_123_2","first-page":"737","article-title":"Randomized placebo\u2010controlled, double\u2010blind trial of ketanserin in treatment of intermittent claudication","volume":"32","author":"Walden R","year":"1991","journal-title":"J Cardiovasc Surg"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198706000-00014"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-199005000-00005"},{"issue":"5","key":"e_1_2_1_126_2","first-page":"S21","article-title":"Implications of thrombosis and vasospasm in peripheral vascular disease","volume":"17","author":"Hollenberg NK","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"e_1_2_1_127_2","first-page":"S95","article-title":"Effect of ketanserin in the treatment of patients with intermittent claudication: Results from 13 placebo\u2010controlled parallel group studies","volume":"10","author":"Clement DL","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.17.5.593"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199006000-00003"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.7.586"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb07791.x"},{"key":"e_1_2_1_132_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00404349"},{"key":"e_1_2_1_133_2","first-page":"337","article-title":"Selective antagonism of S2\u2010serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon","volume":"13","author":"Seibold J","year":"1986","journal-title":"J Rheum"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1986.tb00117.x"},{"key":"e_1_2_1_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80148-2"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331979104200509"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315113"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb05450.x"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02345.x"},{"key":"e_1_2_1_140_2","first-page":"114","article-title":"Comparison of single doses of ketanserin and placebo in chronic stable angina","volume":"22","author":"Cameron HA","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"e_1_2_1_141_2","first-page":"S13","article-title":"Serotonin and thrombotic complications","volume":"17","author":"Willerson JT","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_142_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199301000-00021"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.70.2.178"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/24.11.932"},{"key":"e_1_2_1_145_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103073241002"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.86.1.187"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103073241001"},{"issue":"3","key":"e_1_2_1_148_2","first-page":"101","article-title":"Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty","volume":"8","author":"Klein W","year":"1990","journal-title":"Clin Physiol Biochem"},{"key":"e_1_2_1_149_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053434"},{"issue":"3","key":"e_1_2_1_150_2","first-page":"85","article-title":"Serotonin antagonism in the treatment of cardiac insufficiency","volume":"8","author":"Brune S","year":"1990","journal-title":"Clin Physiol Biochem"},{"key":"e_1_2_1_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92352-7"},{"key":"e_1_2_1_152_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053431"},{"key":"e_1_2_1_153_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053432"},{"key":"e_1_2_1_154_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00054191"},{"key":"e_1_2_1_155_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.85.4.510"},{"issue":"5","key":"e_1_2_1_156_2","first-page":"S1","article-title":"Effects of serotonin on platelets and blood vessels","volume":"17","author":"DeClerck F","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"e_1_2_1_157_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198302000-00016"},{"key":"e_1_2_1_158_2","first-page":"299","article-title":"Role of 5\u2010HT2inhibition in pulmonary embolization","volume":"20","author":"Thompson JA","year":"1986","journal-title":"Circ Shock"},{"key":"e_1_2_1_159_2","first-page":"114","article-title":"Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism","volume":"1355","author":"Huet Y","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_1_160_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-2-258"},{"key":"e_1_2_1_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(87)90200-2"},{"key":"e_1_2_1_162_2","first-page":"519","article-title":"Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis","volume":"14","author":"Seibold JR","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_1_163_2","first-page":"G52","article-title":"Hyperdynamic circulation in portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension","volume":"255","author":"Vorobioff J","year":"1983","journal-title":"Am J Physiol"},{"key":"e_1_2_1_164_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050120"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb11150.x"},{"key":"e_1_2_1_166_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080523"},{"key":"e_1_2_1_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090217"},{"key":"e_1_2_1_168_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0016-5085(90)91302-M","article-title":"Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats","volume":"98","author":"Matsai R","year":"1990","journal-title":"Gastroenterol"},{"key":"e_1_2_1_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140636"},{"key":"e_1_2_1_170_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150521"},{"key":"e_1_2_1_171_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840070405"},{"key":"e_1_2_1_172_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090113"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090114"},{"key":"e_1_2_1_174_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.92.5.863"},{"key":"e_1_2_1_175_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.97.4.901"},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198408000-00008"},{"issue":"2","key":"e_1_2_1_177_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)24858-3","article-title":"Comparative effects of ketanserin, atropine and methysergide on the gastrointestinal effects of hyperserotoninemia in the awake dog","volume":"238","author":"Jaffe B","year":"1965","journal-title":"J Pharm & Exp Ther"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198520110-00012"},{"key":"e_1_2_1_179_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609011123"},{"key":"e_1_2_1_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(87)90121-X"},{"key":"e_1_2_1_181_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1986.tb05456.x"},{"key":"e_1_2_1_182_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1988.tb04340.x"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1995.tb05013.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1995.tb05013.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:39:13Z","timestamp":1745969953000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1995.tb05013.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":181,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["10.1002\/j.1552-4604.1995.tb05013.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1995.tb05013.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}